Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Toxicology and Applied Pharmacology
|
December 1, 2016
Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis
Flavia Lambertucci, Omar Motiño, Silvina Villar, et al.
Cell Death & Disease
|
February 26, 2025
Atlas of expression of acyl CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in human and mouse
Sijing Li, Silvia Mingoia, Léa Montégut, et al.
Toxicology Letters
|
March 17, 2018
Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines
María Paula Ceballos, Giulia Decándido, Ariel Darío Quiroga, et al.
Aging Cell
|
December 13, 2022
High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP
Léa Montégut, Adrien Joseph, Hui Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2026
Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance
Hui Pan, Zhe Shen, Liwei Zhao, et al.
The Journal of Nutritional Biochemistry
|
June 4, 2018
Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet
Flavia Lambertucci, Ainelén Arboatti, María Guillermina Sedlmeier, et al.
Cell Death and Differentiation
|
March 14, 2025
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis
Uxía Nogueira-Recalde, Flavia Lambertucci, Léa Montégut, et al.
Cell Death and Differentiation
|
November 16, 2024
ACBP/DBI neutralization for the experimental treatment of fatty liver disease
Omar Motiño, Flavia Lambertucci, Adrien Joseph, et al.
Autophagy
|
December 12, 2024
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death
Karla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Cell Death & Disease
|
April 6, 2024
Inhibition of acyl-CoA binding protein (ACBP) by means of a GABA<sub>A</sub>Rγ2-derived peptide
Gerasimos Anagnostopoulos, Ester Saavedra, Flavia Lambertucci, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Toxicology and Applied Pharmacology
|
December 1, 2016
Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis
Flavia Lambertucci, Omar Motiño, Silvina Villar, et al.
Cell Death & Disease
|
February 26, 2025
Atlas of expression of acyl CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in human and mouse
Sijing Li, Silvia Mingoia, Léa Montégut, et al.
Toxicology Letters
|
March 17, 2018
Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines
María Paula Ceballos, Giulia Decándido, Ariel Darío Quiroga, et al.
Aging Cell
|
December 13, 2022
High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP
Léa Montégut, Adrien Joseph, Hui Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2026
Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance
Hui Pan, Zhe Shen, Liwei Zhao, et al.
The Journal of Nutritional Biochemistry
|
June 4, 2018
Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet
Flavia Lambertucci, Ainelén Arboatti, María Guillermina Sedlmeier, et al.
Cell Death and Differentiation
|
March 14, 2025
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritis
Uxía Nogueira-Recalde, Flavia Lambertucci, Léa Montégut, et al.
Cell Death and Differentiation
|
November 16, 2024
ACBP/DBI neutralization for the experimental treatment of fatty liver disease
Omar Motiño, Flavia Lambertucci, Adrien Joseph, et al.
Autophagy
|
December 12, 2024
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death
Karla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Cell Death & Disease
|
April 6, 2024
Inhibition of acyl-CoA binding protein (ACBP) by means of a GABA<sub>A</sub>Rγ2-derived peptide
Gerasimos Anagnostopoulos, Ester Saavedra, Flavia Lambertucci, et al.
Page
of 4